Ipsen S.A.
(OTC: IPSEY)
|
1:59 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $30.81 | Change: +0.53 | %Change: +1.75% | Volume: 277 |
Open: | $ 30.81 | Volume: | 277 | |
---|---|---|---|---|
High: | $ 30.81 | Yield(%) | 0.77 | |
Low: | $ 30.81 | P/E Ratio (ttm): | 14.52 | |
Dividend ($): | 0.24 | Market Cap ($): | 10.10B | |
EPS ($) | n/a | Shares Out: | 330.56M |
% Price Change (last 4 weeks): | -7.36 |
---|---|
% Price Change (last 13 weeks): | 7.03 |
% Price Change (last 26 weeks): | 2.58 |
% Price Change (last 52 weeks): | 2.18 |
% Price Change (year to date): | 2.56 |
Return on Equity (%): | 17.13 |
---|---|
Return on Assets (%): | 10.29 |
Return on Invested Capital (%): | 13.48 |
Gross Profit Margin (%): | 75.10 |
---|---|
Net Profit Margin (%): | 19.73 |
Operating Profit Margin (%): | 20.75 |
|
|
50-day Moving Average: | $22.29 |
---|---|
200-day Moving Average: | $23.06 |
Avg. Daily Vol. (last 50 days): | 712 |
Avg. Daily Vol. (last 200 days): | 1,094 |
52-wk high: | $34.34 |
52-wk low: | $26.97 |
Bid: | $n/a |
Ask: | $n/a |
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.
|
Ipsen S.A.
65, quai Georges Gorse Boulogne-Billancourt IF 92650 Phone: 33.1.58.33.50.00 Fax: 33.1.58.33.50.01 http://www.ipsen.com |
Earnings (1year) ($): | 2.11 |
---|---|
Annual Dividend ($): | 0.24 |
Current P/E Ratio (ttm): | 14.52 |
Book Value ($): | 12.78 |
Cash Flow ($): | 3.08 |
Price/Earnings (x): | 14.52 |
---|---|
Price/Sales (x): | 2.94 |
Price/Book (x): | 2.33 |
Price/Cash Flow (x): | 10.90 |
Quick Ratio (x): | 0.99 |
---|---|
Current Ratio (x): | 1.17 |
LT Debt/Equity (x): | 8.93 |
Total Debt/Equity (x): | 12.10 |